PalOctPGM: Difference between revisions
From Bioblast
(Created page with "{{MitoPedia |abbr=PalOctPGM |description='''PalOctPGM''': Palmitoylcarnitine & Octanoylcarnitine & Pyruvate & Glutamate & Malate. '''MitoPathway control s...") |
Beno Marija (talk | contribs) No edit summary |
||
| Line 14: | Line 14: | ||
::::» [[Fatty acid oxidation pathway control state]] | ::::» [[Fatty acid oxidation pathway control state]] | ||
::::» [[FN]] | ::::» [[FN]] | ||
::::» [[NADH | ::::» [[NADH electron transfer-pathway state]] | ||
== PalOctPGM<sub>''L''</sub> == | == PalOctPGM<sub>''L''</sub> == | ||
Latest revision as of 14:36, 26 August 2020
- high-resolution terminology - matching measurements at high-resolution
PalOctPGM
Description
PalOctPGM: Palmitoylcarnitine & Octanoylcarnitine & Pyruvate & Glutamate & Malate.
MitoPathway control state: FN
SUIT protocols: SUIT-019
Abbreviation: PalOctPGM
Reference: SUIT reference protocol
MitoPedia concepts:
SUIT state
- More details
PalOctPGML
PalOctPGM in the LEAK state can be evaluated in the following SUIT protocols:
PalOctPGMP
PalOctPGM in the OXPHOS state can be evaluated in the following SUIT protocols:
PalOctPGME
PalOctPGM in the ET state can be evaluated in the following SUIT protocols:
